FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved Allergan's supplemental application for OXYTROL (oxybutynin). The approval updates the product labeling under NDA 021351.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• OXYTROL (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL (OXYBUTYNIN)